Performance of CD3xCD19 bispecific monoclonal antibodies in B cell malignancy
IA Haagen - Leukemia & Lymphoma, 1995 - Taylor & Francis
Bispecific monoclonal antibodies, with a dual specificity for tumor associated antigens on
target cells and for surface markers on immune effector cells, have been shown (in vitro) to …
target cells and for surface markers on immune effector cells, have been shown (in vitro) to …
Performance of CD3xCD19 bispecific monoclonal antibodies in B cell malignancy
IA Haagen - Leukemia & lymphoma, 1995 - pubmed.ncbi.nlm.nih.gov
Bispecific monoclonal antibodies, with a dual specificity for tumor associated antigens on
target cells and for surface markers on immune effector cells, have been shown (in vitro) to …
target cells and for surface markers on immune effector cells, have been shown (in vitro) to …
Performance of CD3xCD19 bispecific monoclonal antibodies in B cell malignancy.
IA Haagen - Leukemia & Lymphoma, 1995 - europepmc.org
Bispecific monoclonal antibodies, with a dual specificity for tumor associated antigens on
target cells and for surface markers on immune effector cells, have been shown (in vitro) to …
target cells and for surface markers on immune effector cells, have been shown (in vitro) to …